Medpace Holdings, Inc.
MEDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14,928 | $9,255 | $9,259 | $10,281 |
| - Cash | $285 | $46 | $441 | $669 |
| + Debt | $144 | $150 | $127 | $126 |
| Enterprise Value | $14,786 | $9,359 | $8,944 | $9,738 |
| Revenue | $660 | $603 | $559 | $537 |
| % Growth | 9.4% | 8% | 4.1% | – |
| Gross Profit | $197 | $180 | $178 | $178 |
| % Margin | 29.8% | 29.8% | 31.9% | 33.2% |
| EBITDA | $150 | $118 | $120 | $133 |
| % Margin | 22.7% | 19.5% | 21.6% | 24.8% |
| Net Income | $111 | $90 | $115 | $117 |
| % Margin | 16.8% | 15% | 20.5% | 21.8% |
| EPS Diluted | 3.87 | 3.1 | 3.67 | 3.67 |
| % Growth | 24.8% | -15.5% | 0% | – |
| Operating Cash Flow | $246 | $149 | $126 | $191 |
| Capital Expenditures | $16 | -$6 | -$10 | -$8 |
| Free Cash Flow | $262 | $142 | $116 | $183 |